1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 21 SEPTEMBER 2015

Key Pharma News 21 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 11 pages

Industry Trend Analysis - Amgen Pipeline Needs To Increase Generation Of Marketable Products
Industry Brief - Evotec And Pfizer Enter Tissue Fibrosis Collaboration
Industry Trend Analysis - Acquisitions Will Establish A Firm Cornerstone For Cipla
Industry Brief - Sun Acquires Opiates Business In Australia
Industry Brief - Pfizer Completes Hospira Acquisition
Industry Brief - FDA Approves Octapharma's Nuwiq For Haemophilia A
Industry Brief - AbbVie's Humira Becomes Only FDA Approved Therapy For HS
Industry Trend Analysis - Merck KGaA's Oral Cladribine Will Find Position In Crowded Market
Industry Brief - Takeda's Ixazomib Granted Priority Review for r/r MM
Industry Brief - Alvogen Launches First Generic Rivastigmine Patch In US
Industry Brief - Lupin Launches New Duloxetine Strength
Industry Brief - Biosimilar Etanercept Approved In South Korea
Industry Brief - Oxaydo Launched In US
Industry Trend Analysis - RPI-78M Orphan Status Will Spur Development
Industry Brief - Allergan Settles Namenda XR Patent Litigation With Amneal
Industry Brief - FDA Grants Breakthrough Therapy Designation To Opdivo For Advanced RCC
Industry Trend Analysis - Phase III Aducanumab Trial Is High Risk But High Reward
Industry Brief - Takeda Joins WIPO Re:Search To Accelerate NTD R&D
Industry Brief - Revefenacin Phase III Programme Initiated In COPD Patients

Table Of Contents

Key Pharma News 21 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.